Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 3/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.46 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.44 |
| ▸ | GNPAT | O15228 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | MMP7 | P09237 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | MMP12 | P39900 | 1/20 | 0.43 |
| ▸ | MMP13 | P45452 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
| ▸ | CPA1 | P15085 | 1/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5598789 | 1.00 | MME (0.46) | MMEITGB3ITGA2BSLC15A2GNPAT | |
| SCHEMBL30692732 | 1.00 | MME (0.46) | MMEITGB3ITGA2BSLC15A2GNPAT | |
| SCHEMBL4589435 | 0.99 | MME (0.45) | MMEITGB3ITGA2BSLC15A2GNPAT | |
| SCHEMBL2244563 | 0.99 | MME (0.45) | MMEITGB3ITGA2BSLC15A2GNPAT | |
| SCHEMBL7806530 | 0.92 | SLC15A2 (0.54) | ITGB3ITGA2BSLC15A2GNPAT | |
| SCHEMBL7799086 | 0.92 | SLC15A2 (0.54) | ITGB3ITGA2BSLC15A2GNPAT | |
| SCHEMBL8012953 | 0.92 | SLC15A2 (0.54) | ITGB3ITGA2BSLC15A2GNPAT | |
| SCHEMBL9390320 | 0.92 | SLC15A2 (0.54) | ITGB3ITGA2BSLC15A2GNPAT | |
| SCHEMBL31453803 | 0.92 | SLC15A2 (0.49) | MMEITGB3ITGA2BSLC15A2 | |
| SCHEMBL20783813 | 0.92 | SLC15A2 (0.49) | MMEITGB3ITGA2BSLC15A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026040002-A1 | COMPOSITION AND METHOD FOR CARING FOR THE SKIN | L'OREAL (FR) | 2026-02-26 | — | — | WO | claimed |
| WO-2026040002-A1 | COMPOSITION AND METHOD FOR CARING FOR THE SKIN | L'OREAL (FR) | 2026-02-26 | — | — | WO | disclosed |
| US-7186687-B2 | Compositions and methods for treatment of Psoriasis | PROCYTE CORPORATION (US) | 2007-03-06 | — | — | US | disclosed |
| EP-0765152-B1 | STIMULATION OF HAIR GROWTH BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORP (US) | 2001-11-07 | — | — | EP | disclosed |
| US-6017888-A | Stimulation of hair growth by peptide copper complexes | PROCYTE CORPORATION (US) | 2000-01-25 | — | — | US | disclosed |
| EP-0765152-A1 | STIMULATION OF HAIR GROWTH BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1997-04-02 | — | — | EP | disclosed |
| US-5538945-A | Stimulation of hair growth by peptide copper complexes | PROCYTE CORPORATION (US) | 1996-07-23 | — | — | US | disclosed |
| WO-1995035085-A1 | STIMULATION OF HAIR GROWTH BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1995-12-28 | — | — | WO | disclosed |
| WO-1994018230-A1 | INHIBITION OF HIV REPLICATION BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1994-08-18 | — | — | WO | disclosed |
| US-4591648-A | Histidine protection | NATIONAL RESEARCH DEVELOPMENT CORP. (GB) | 1986-05-27 | — | — | US | disclosed |
| EP-0061933-B1 | HISTIDINE PROTECTION | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1985-03-27 | — | — | EP | disclosed |
| EP-0061933-A2 | Histidine protection | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1982-10-06 | — | — | EP | disclosed |